Methods and compounds to modulate Huntington's disease

CL202601033A1Pending Publication Date: 2026-07-03DESIGN THERAPEUTICS INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CL202601033
Authority / Receiving Office: CL · CL
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-10-03
Filing Date: 2026-04-01
Publication Date: 2026-07-03

Application Information

Patent Timeline

03 Oct 2024

Priority

01 Apr 2026

Application

CL202601033

03 Jul 2026

Publication

CL202601033A1

IPC: A61K47/55; A61K47/59; A61P25/28; C07D207/416; C07D233/66; C07D401/14; C07D403/12; C07D403/14; C07D405/14; C07D413/14; C07D471/04; C07D495/14

CPC: A61P25/28; C07D495/14; C07D471/04; C07D413/14; C07D401/14; C07D403/14; C07D405/14; C07D403/12

Inventors: NOURIE Hannah; SINHA Santosh

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present description relates to transcription modulator molecules having a first end, a second end and an oligomeric backbone and methods for treating Huntington's disease (HD).

Need to check novelty before this filing date? Find Prior Art